These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 17099873

  • 1. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.
    Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, Gessler M.
    Genes Chromosomes Cancer; 2007 Feb; 46(2):163-70. PubMed ID: 17099873
    [Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM, National Wilms Tumor Study Group.
    J Clin Oncol; 2005 Oct 10; 23(29):7312-21. PubMed ID: 16129848
    [Abstract] [Full Text] [Related]

  • 3. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC.
    Cancer Res; 1994 May 01; 54(9):2331-3. PubMed ID: 8162576
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P, Telzerow P, Moksness J, Breslow NE.
    Med Pediatr Oncol; 1996 Nov 01; 27(5):429-33. PubMed ID: 8926924
    [Abstract] [Full Text] [Related]

  • 5. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, Szymik-Kantorowicz S, Daszkiewicz P, Debiec-Rychter M.
    Eur J Surg Oncol; 2000 Feb 01; 26(1):61-6. PubMed ID: 10718182
    [Abstract] [Full Text] [Related]

  • 6. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Watanabe N, Nakadate H, Haruta M, Sugawara W, Sasaki F, Tsunematsu Y, Kikuta A, Fukuzawa M, Okita H, Hata J, Soejima H, Kaneko Y.
    Genes Chromosomes Cancer; 2006 Jun 01; 45(6):592-601. PubMed ID: 16518847
    [Abstract] [Full Text] [Related]

  • 7. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene.
    Yeh A, Wei M, Golub SB, Yamashiro DJ, Murty VV, Tycko B.
    Genes Chromosomes Cancer; 2002 Oct 01; 35(2):156-63. PubMed ID: 12203779
    [Abstract] [Full Text] [Related]

  • 8. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters.
    Klamt B, Schulze M, Thäte C, Mares J, Goetz P, Kodet R, Scheulen W, Weirich A, Graf N, Gessler M.
    Genes Chromosomes Cancer; 1998 Aug 01; 22(4):287-94. PubMed ID: 9669666
    [Abstract] [Full Text] [Related]

  • 9. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B.
    Mol Cancer Res; 2005 Sep 01; 3(9):493-502. PubMed ID: 16179496
    [Abstract] [Full Text] [Related]

  • 10. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor.
    Mason JE, Goodfellow PJ, Grundy PE, Skinner MA.
    J Pediatr Surg; 2000 Jun 01; 35(6):891-6; discussion 896-7. PubMed ID: 10873032
    [Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, Mccallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moerland EW, Smit VT, Harris WH, Millis R, Morgan NV, Barnes D, Mathew CG, Cornelisse CJ.
    Cancer Res; 2001 Feb 01; 61(3):1171-7. PubMed ID: 11221848
    [Abstract] [Full Text] [Related]

  • 12. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM, Buerger H, Haar Nt, Philippo K, van de Vijver MJ, Boecker W, Smit VT, Cornelisse CJ.
    Genes Chromosomes Cancer; 2004 Oct 01; 41(2):109-16. PubMed ID: 15287023
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M, Devilee P, Bliek J, Mandjes I, de Kraker J, Heyting C, Slater RM, Westerveld A.
    Cancer Res; 1990 Jun 01; 50(11):3279-83. PubMed ID: 2159377
    [Abstract] [Full Text] [Related]

  • 14. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R, Hero B, Simon T, Berthold F.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [Abstract] [Full Text] [Related]

  • 15. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD, Freemerman AJ, Langdon S, Bentley R, Goyeau D, Grundy PE, Skinner MA.
    J Pediatr Surg; 2005 Feb 01; 40(2):341-8. PubMed ID: 15750927
    [Abstract] [Full Text] [Related]

  • 16. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
    Karnik P, Chen P, Paris M, Yeger H, Williams BR.
    Oncogene; 1998 Jul 16; 17(2):237-40. PubMed ID: 9674708
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity for chromosome 14q in neuroblastoma.
    Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS.
    Med Pediatr Oncol; 2001 Jan 16; 36(1):28-31. PubMed ID: 11464899
    [Abstract] [Full Text] [Related]

  • 18. Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor.
    Tamimi Y, Ziebart K, Desaulniers N, Dietrich K, Grundy P.
    Genes Chromosomes Cancer; 2007 Apr 16; 46(4):327-35. PubMed ID: 17243164
    [Abstract] [Full Text] [Related]

  • 19. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
    Grundy RG, Pritchard J, Scambler P, Cowell JK.
    Br J Cancer; 1998 Nov 16; 78(9):1181-7. PubMed ID: 9820177
    [Abstract] [Full Text] [Related]

  • 20. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
    Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM.
    Med Pediatr Oncol; 2001 Jan 16; 36(1):24-7. PubMed ID: 11464895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.